APA (7th ed.) Citation

Kang, B., Zhang, X., Wang, W., She, S., Chen, W., Chen, C., . . . Wang, Y. (2022). The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer. Cancers, 14(23), 5747. https://doi.org/10.3390/cancers14235747

Chicago Style (17th ed.) Citation

Kang, Bo, et al. "The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole Against Colorectal Cancer." Cancers 14, no. 23 (2022): 5747. https://doi.org/10.3390/cancers14235747.

MLA (9th ed.) Citation

Kang, Bo, et al. "The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole Against Colorectal Cancer." Cancers, vol. 14, no. 23, 2022, p. 5747, https://doi.org/10.3390/cancers14235747.